Quetiapine Fumarate Tablet
Product Images NDC 50268-635

9 FDA label images from Avpak · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 50268-635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Quetiapine Stru)

Structure (Quetiapine Stru)
Chemical structure of quetiapine fumarate, showing the molecular arrangement of atoms including rings, nitrogen, oxygen, and sulfur components characteristic of quetiapine, paired with the fumarate moiety.*
FDA Label Image

Quetiapine-fig1 (Quetiapine Fig1)

Quetiapine-fig1 (Quetiapine Fig1)
A Kaplan-Meier curve showing the proportion of patients with relapse of a mood event over time in weeks. Two treatment groups are compared: QTP + LI/VAL (quetiapine fumarate plus lithium/valproate) and PLA + LI/VAL (placebo plus lithium/valproate). The graph depicts the relapse rates up to 100 weeks, indicating differences between the treatments.*
FDA Label Image

Quetiapine-fig2 (Quetiapine Fig2)

Quetiapine-fig2 (Quetiapine Fig2)
A Kaplan-Meier curve showing time to recurrence of a mood event over 100 weeks. The y-axis represents the proportion of patients with relapse (%), and the x-axis shows time (weeks). Two curves compare QTP+LIVAL and PLA+LIVAL groups, depicting the proportion of relapses over time in a clinical study.*
FDA Label Image

1 (630 15)

1 (630 15)
Quetiapine Tablets, USP 25 mg oral tablets in a carton containing 50 tablets (5 x 10) unit dose packs. The label states Rx only and includes storage instructions and manufacturer AvPAK information. The NDC number is 50268-630-15. There are two identical panels shown on the label.*
FDA Label Image

2 (631 15)

2 (631 15)
Quetiapine Tablets, USP 50 mg oral tablets by AvPAK shown on a carton label. The package contains 50 tablets (5 bottles of 10 tablets each) with NDC 50268-631-15. Label includes dosage strength, barcode, storage instructions, and a warning to keep out of reach of children. Manufacturer details and batch dates are also visible.*
FDA Label Image

3 (632 15)

3 (632 15)
Label for Quetiapine Tablets, USP, 100 mg oral tablets, manufactured by AvPAK. The label specifies a unit dose package containing 50 tablets (5 x 10) with Rx Only designation. It includes dispensing instructions, storage conditions, a barcode, and manufacturer information including address and website.*
FDA Label Image

1 (633 15)

1 (633 15)
Label for Quetiapine Tablets, USP 200 mg oral tablets, packaged as 50 tablets in unit dose format (5 x 10). The label indicates prescription only, with dosage strength highlighted in orange. Manufactured by AvPAK in Pulaski, Tennessee. Additional storage and usage information is noted along with a barcode and the AvPAK logo.*
FDA Label Image

1 (634 15)

1 (634 15)
Quetiapine Tablets USP 300 mg oral tablets by AvPAK shown on a printed label. The label includes NDC 50268-634-15, Rx only designation, package size of 50 tablets (5x10 unit dose), a barcode, dosing information for quetiapine fumarate equivalent to 300 mg quetiapine, manufacturer details, and a warning to keep medication away from children. The label also includes a QR code and AvPAK logo.*
FDA Label Image

1 (635 15)

1 (635 15)
Quetiapine Tablets, USP 400 mg oral tablets in a unit dose packaging of 50 tablets (5 x 10). The label includes directions to dispense the medication guide separately and storage conditions. Manufactured by AvPAK, Pulaski, TN, with the product NDC 50268-635-15. The packaging also highlights the prescription-only status and includes a barcode and QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.